Lytix Biopharma – Innovations in Killing Cancer
Update: 2024-03-07
Description
Following recent encouraging interim clinical results, hear Øystein Rekdal, CEO of Lytix Biopharma, discuss with Optimum's Nick Bastin how the company's lead candidate LTX-315 has a unique approach to killing cancer.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel